文章摘要
鲍颖,梁颜,何丽,等.两种不同类型门冬酰胺酶在成人急性淋巴细胞白血病治疗中的疗效观察[J].安徽医药,2018,22(12):2435-2437.
两种不同类型门冬酰胺酶在成人急性淋巴细胞白血病治疗中的疗效观察
The clinical efficacy of two different types of asparaginase in adult patients with acute lymphoblastic leukemia
投稿时间:2017-03-29  
DOI:
中文关键词: 急性淋巴细胞白血病  化疗  门冬酰胺酶  不良反应
英文关键词: Acute lymphoblastic leukemia  Chemotherapy  Asparaginase  Adverse effects
基金项目:
作者单位
鲍颖 湖北医药学院附属襄阳医院,湖北 襄阳 441000 
梁颜 湖北医药学院附属襄阳医院,湖北 襄阳 441000 
何丽 湖北医药学院附属襄阳医院,湖北 襄阳 441000 
代喆 武汉大学中南医院内分泌科,湖北 武汉 430000 
摘要点击次数: 1981
全文下载次数: 813
中文摘要:
      目的 比较应用不同门冬酰胺酶的VDLP方案在急性淋巴细胞白血病(ALL)患者中的近期、远期疗效及安全性。 方法前瞻性收集湖北医药学院附属襄阳医院血液科2010年1月至2012年1月确诊为ALL的成人患者95例。根据治疗方案的不同采用随机数字表法分为A组[培门冬酶(PEG-Asp)的VDLP方案]52例和B组[左旋门冬酰胺酶(L-Asp)的VDLP方案]43例。比较两组的基线资料、初始病情、近期及远期疗效、治疗不良反应。 结果 两组的基线资料、初发病情、近期、远期疗效组间均差异无统计学意义(P>0.05);A组过敏反应5例,B组为11例,A组过敏反应发生率显著低于B组(P<0.05),其余不良反应发生率两组均差异无统计学意义(P>0.05)。 结论 PEG-Asp及L-Asp两种不同VDLP方案在ALL患者中近期、远期疗效相当,但PEG-Asp过敏反应率更低,有较高的临床应用价值。
英文摘要:
      Objective To compare the short-term,long-term curative effects and security of VDLP regimens with different asparaginase in adult patients with acute lymphoblastic leukemia (ALL). Methods The clinical information of adult patients diagnosed with ALL received treatment at our hospital from Jan 2010 to Jan 2012 was prospectively analyzed.Patients included were randomly divided into two groups according to the therapeutic regimen,group A (VDLP regimen with PEG-Asp) and group B (VDLP regimen with L-Asp).The baseline data,the initial condition,the short-term,long-term curative effects and adverse effects in these two groups were compared. Results 95 patients were enrolled in this research,including 52 patients in group Aand 43 in group B.The baseline data,the initial condition,the short-termand long-term curative effects in two groups were with no significant difference (P>0.05).Patients in group Awere with a significant lower incidence of allergic response than group B (5 vs.11,P<0.05).Other adverse effects in these two groups were also with no significant difference (P>0.05). Conclusion Compared with VDLP regimen with L-Asp,VDLP regimen with PEG-Asp had a close efficacy,a lower incidence of allergic response and a greater clinical value.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮